Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Linezolid for patients with neutropenia: are bacteriostatic agents appropriate
Expert Review of Anti-infective Therapy, 05/07/09
Rafailidis PI et al. - The available evidence suggests that linezolid may be successful in a significant proportion of neutropenic patients with infection, despite the fact that it is a bacteriostatic agent. Such data seem to justify further studies regarding the role of linezolid in this patient population.
Related Articles
A comparison of linezolid with glycopeptides in severe MRSA pneumonia
Expert Review of Anti-infective Therapy, 10/09/09
Relevance Score: 87%
Linezolid therapy for pediatric thoracic spondylodiscitis due to Staphylococcus aureus sepsis
International Journal of Infectious Diseases, 11/17/09
Relevance Score: 80%
Acute Granulomatous Acanthamoeba Encephalitis in an Immunocompetent Patient
Neurocritical Care, 10/26/09
Relevance Score: 80%
Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09
Relevance Score: 77%
Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies
Antimicrobial Agents and Chemotherapy, 10/02/09
Relevance Score: 77%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/18/09
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
Clinical Pharmacokinetics, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


